Huber Jeff
Known title: DirectorCIK: 0001463740
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Summit Therapeutics Partners With AstraZeneca and Daiichi Sankyo. Summit Therapeutics announced a new collaboration with AstraZeneca and Daiichi Sankyo to test a cancer therapy combination. This partnership involves an ADC-bispecific approach and was described by the CEO as an important expansion of the company’s work. The stock rose 7.3% following the news, reflecting investor interest in this strategic alliance.
Transaction History
| UPST | ▲ Buy | Grant | 4,314 | $0 | 5/27/2025 | View on chart |
| UPST | ▲ Buy | Grant | 542 | $0 | 1/10/2025 | View on chart |
| SMMT | ▲ Buy | Grant | 44,052 | $1000K | 9/11/2024 | View on chart |
| UPST | ▲ Buy | Grant | 8,278 | $0 | 5/30/2024 | View on chart |
| UPST | ▲ Buy | Grant | 1,038 | $0 | 1/10/2024 | View on chart |
| UPST | ▲ Buy | Grant | 9,669 | $0 | 5/25/2023 | View on chart |
| UPST | ▲ Buy | Grant | 2,503 | $0 | 1/10/2023 | View on chart |
| UPST | ▲ Buy | Grant | 1,991 | $0 | 5/18/2022 | View on chart |
| UPST | ▲ Buy | Grant | 102 | $0 | 1/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Upstart Expands Credit Union Partnership and Receives Rating Upgrade
Upstart announced a new partnership with the Credit Union of Denver to broaden its personal‑lending reach. The move follows a recent rating upgrade that highlighted the company as cheaper but less safe. Analysts noted a short second half for the year, and the stock fell as the broader market gained. The partnership may help diversify Upstart’s loan portfolio amid ongoing market volatility.
Upstart Expands Credit Union Partnership and Receives Rating Upgrade. Upstart announced a new partnership with the Credit Union of Denver to broaden its personal‑lending reach. The move follows a recent rating upgrade that highlighted the company as cheaper but less safe. Analysts noted a short second half for the year, and the stock fell as the broader market gained. The partnership may help diversify Upstart’s loan portfolio amid ongoing market volatility.